Europe Liquid Biopsy Market Analysis, Size, Share and Key Segments Poised 2027


The Europe liquid biopsy market is expected to reach US$ 2,251.12 Mn in 2027 from US$ 1,017.60 Mn in 2018. The market is anticipated to grow with a CAGR of 9.5% from 2019-2027. Factors driving the market growth include government and global health organizations initiatives. However, low sensitivity of liquid biopsy is likely to have a negative impact on market growth.

Europe liquid biopsy market Introduction
Europe liquid biopsy market is a groundbreaking diagnostic technology that offers new possibilities in cancer detection and monitoring. It involves the isolation and analysis of circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and exosomes—providing critical genomic insights into a patient’s cancer. Liquid biopsies are particularly valuable in evaluating treatment response and detecting resistance, making them a vital tool in oncology.

The European Society for Medical Oncology (ESMO), a leading organization in the field, continues to support oncology professionals in delivering high-quality patient care, particularly during challenging times such as the COVID-19 pandemic. The pandemic significantly affected cancer patients, leading to increased anxiety, fear, and psychological stress. Additionally, widespread lockdowns and extended quarantine periods disrupted supply chains, delaying the availability of diagnostic kits and assays. As of March 26, 2020, Europe had reported approximately 250,000 COVID-19 cases, with countries like Italy, Spain, Germany, France, and the UK experiencing severe impacts.

Strategic Insights: Europe Liquid Biopsy Market
Strategic insights into the Europe liquid biopsy market offer a data-driven analysis of industry trends, key players, and regional dynamics. These insights equip stakeholders with actionable intelligence, helping them uncover untapped opportunities, create differentiated offerings, and remain competitive. Through robust data analytics, companies can anticipate market trends, adapt strategies accordingly, and secure long-term success. Whether you're an investor, manufacturer, or healthcare provider, these insights serve as a roadmap for informed decision-making, profitability, and sustainable growth.

Regional Insights: Europe Liquid Biopsy Market
Understanding the geographical landscape is essential for success in the European liquid biopsy market. Local variations—such as consumer preferences, economic conditions, and regulatory frameworks—require customized approaches. Businesses that recognize underserved regions or adapt their offerings to meet specific local needs can better position themselves in the market. A well-defined regional strategy enables efficient resource allocation, focused marketing efforts, and stronger competitiveness, ultimately fostering growth and market penetration.

Key Market Segments

  • By Product & Services: Reagents and kits dominated the European liquid biopsy market in 2018, accounting for the largest market share.
  • By Sample Type: The blood-based sample segment is expected to maintain the largest market share through 2027.
  • By Circulating Biomarker: Circulating tumor cells (CTCs) held the largest share of the market in 2019.
  • By Application: Oncology is projected to remain the leading application segment by 2027.
  • By End User: Reference laboratories are anticipated to retain the largest share of the market by 2027.

Segmentation

Europe liquid biopsy market By Product & Service

  • Equipment
  • Reagents & Kits
  • Services

Europe liquid biopsy market By Sample

  • Blood Based
  • Urine Based
  • Other samples

Europe liquid biopsy market By Circulating Biomarker

  • Circulating Tumor Cells (CTC)
  • Exosomes
  • Free Nucleic Acid

Europe liquid biopsy market By Application

  • Noninvasive Prenatal Testing (NIPT)
  • Oncology
  • Transplant Diagnostics
  • Other Applications

Europe liquid biopsy market By End User

  • Academic & Research Institutes
  • Hospitals
  • Reference Laboratories
  • Other End Users

Europe liquid biopsy market By Geography

  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain

Company Profiles

  • F. Hoffmann-la Roche ltd
  • Inivata Ltd
  • LungLife AI, Inc.
  • Exosome Diagnostics
  • MDxHealth

Other Report:

Europe Metagenomics Market: https://sites.google.com/view/europe-metagenomics-market/home 

North America Fluoroelastomers Market: https://business-news-insights.blogspot.com/2025/04/north-america-fluoroelastomers-market.html 

North America Green Hydrogen Market: https://postyourarticle.com/north-america-green-hydrogen-market-trends-key-vendors-analysis-growth-2030/   

North America Autonomous Mobile Robots Market: https://penzu.com/p/0709f189639184ca  

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

Author’s Bio:

Suryakant Gadekar

Senior Market Research Expert at Business Market Insights

Comments

Popular posts from this blog

North America Small Satellite Market Trends, Opportunity and Forecast 2022 to 2028

North America Small Satellite Market Current Status by 2028 Top Players

North America Small Satellite Market Latest Innovations, Top Players Forecast 2028